Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

615
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
615
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

277
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
277
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.0K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
126
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa.

Pediatric dermatology·2026
Same author

Pearls and Pitfalls of Treating Vulvar Disease.

Clinical obstetrics and gynecology·2026
Same author

Characterization of TNF-Alpha Inhibitor Induced Paradoxical Psoriasiform Dermatitis at a Single Center via Retrospective Chart Review.

Pediatric dermatology·2026
Same author

Neonatal Inflammatory Skin and Bowel Disease 1 (NISBD1): A Case of ADAM17 Homozygous Mutation.

Pediatric dermatology·2025
Same author

Advances in Pediatric Dermatology Research from the 2024 PeDRA Annual Conference.

The Journal of investigative dermatology·2025
Same author

"Vulva," Not "Private Part": The Importance of Accurate Genital Terminology.

Pediatric dermatology·2024

Related Experiment Video

Updated: Jun 26, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

12.2K

Atopic Dermatitis: Managing the Itch.

William S Farmer1, Kalyani S Marathe2

  • 1Georgetown University School of Medicine, Washington, DC, USA.

Advances in Experimental Medicine and Biology
|May 9, 2024
PubMed
Summary

Managing atopic dermatitis pruritus involves a stepwise approach, starting with non-pharmaceutical interventions and progressing to topical and systemic therapies. Phototherapy offers a significant improvement for itch relief at any treatment stage.

Keywords:
AppearanceAtopic dermatitisCheilitisErythemaHyperpigmentationIchthyosisLichenificationNocturnal pruritusPruritusPsychological well-beingQuality of lifeSleepTransient receptor potential (TRPV1)

More Related Videos

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

9.7K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K

Related Experiment Videos

Last Updated: Jun 26, 2025

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
04:59

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors

Published on: September 27, 2019

12.2K
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

9.7K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K

Area of Science:

  • Dermatology
  • Clinical Therapeutics
  • Pruritus Management

Background:

  • Atopic dermatitis significantly impairs quality of life, affecting sleep, appearance, and psychological well-being.
  • Visible symptoms like lichenification and erythema can cause social stigma, complicating patient management.
  • Pruritus is a central symptom, necessitating effective and structured treatment strategies.

Purpose of the Study:

  • To outline a therapeutic ladder for managing pruritus in atopic dermatitis.
  • To detail various treatment modalities for practitioners advising patients.
  • To emphasize a systematic approach to symptom control.

Main Methods:

  • Assessment and documentation of pruritus using questionnaires at routine visits.
  • Initial recommendation of non-pharmaceutical treatments: emollients, wet wraps, trigger elimination, behavioral changes, and psychological interventions.
  • Sequential introduction of pharmacological therapies based on treatment response and disease severity.

Main Results:

  • First-line topical agents include topical glucocorticoids and calcineurin inhibitors.
  • Second-line topical options comprise coal tar, menthol, capsaicin, and doxepin.
  • Systemic agents (antihistamines, oral glucocorticoids, cyclosporine A) and neuromodulating/immunomodulating agents are considered after topical therapies.
  • Phototherapy demonstrates dramatic improvement in pruritus and can be used as a first-line option.

Conclusions:

  • A structured, stepwise therapeutic approach is crucial for effective atopic dermatitis pruritus management.
  • Non-pharmaceutical interventions should be prioritized before escalating to pharmacological treatments.
  • Phototherapy is a valuable, versatile treatment option for pruritus in atopic dermatitis.